(Q39704107)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20467453%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

title

Knockdown of Efp by DNA-modified small interfering RNA inhibits breast cancer cell proliferation and in vivo tumor growth (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20467453%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20467453%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

author name string

K Ueyama

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20467453%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

K Ikeda

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20467453%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

W Sato

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20467453%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

N Nakasato

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20467453%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

K Horie-Inoue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20467453%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

S Inoue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20467453%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

publication date

14 May 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20467453%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20467453%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20467453%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20467453%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

page(s)

624-632

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20467453%20AND%20SRC:MED&resulttype=core&format=json

Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer

2 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.19

21 January 2018

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.19

7 January 2021

Estrogen carcinogenesis in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.19

7 January 2021

Genomic binding-site cloning reveals an estrogen-responsive gene that encodes a RING finger protein

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.19

7 January 2021

Efp as a primary estrogen-responsive gene in human breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.19

7 January 2021

Molecular cloning, structure, and expression of mouse estrogen-responsive finger protein Efp. Co-localization with estrogen receptor mRNA in target organs

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.19

7 January 2021

Underdeveloped uterus and reduced estrogen responsiveness in mice with disruption of the estrogen-responsive finger protein gene, which is a direct target of estrogen receptor alpha.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.19

7 January 2021

Estrogen-responsive finger protein as a new potential biomarker for breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.19

7 January 2021

Efp targets 14-3-3 sigma for proteolysis and promotes breast tumour growth

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.19

7 January 2021

RNAi therapeutics: principles, prospects and challenges

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.19

7 January 2021

Applications of RNA interference: current state and prospects for siRNA-based strategies in vivo

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.19

7 January 2021

The therapeutic potential of RNA interference

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.19

7 January 2021

Strategies for silencing human disease using RNA interference

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.19

7 January 2021

Off-target effects by siRNA can induce toxic phenotype

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.19

7 January 2021

Overcoming the innate immune response to small interfering RNA.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.19

7 January 2021

Functional dissection of siRNA sequence by systematic DNA substitution: modified siRNA with a DNA seed arm is a powerful tool for mammalian gene silencing with significantly reduced off-target effect.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.19

7 January 2021

dsCheck: highly sensitive off-target search software for double-stranded RNA-mediated RNA interference.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.19

7 January 2021

siDirect: highly effective, target-specific siRNA design software for mammalian RNA interference

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.19

7 January 2021

Identification of novel steroid target genes through the combination of bioinformatics and functional analysis of hormone response elements

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.19

7 January 2021

Atu027, a liposomal small interfering RNA formulation targeting protein kinase N3, inhibits cancer progression.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.19

7 January 2021

3' UTR seed matches, but not overall identity, are associated with RNAi off-targets

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.19

7 January 2021

Design of noninflammatory synthetic siRNA mediating potent gene silencing in vivo

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.19

7 January 2021

14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.19

7 January 2021

TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.19

7 January 2021

Ligand-dependent transcription of estrogen receptor alpha is mediated by the ubiquitin ligase EFP.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.19

7 January 2021

Regulation of the p53-MDM2 pathway by 14-3-3 sigma and other proteins.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.19

7 January 2021

Endocrine-responsive breast cancer and strategies for combating resistance

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.19

7 January 2021

Overview of resistance to systemic therapy in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.19

7 January 2021

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.19

7 January 2021

Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.19

7 January 2021

Rational management of endocrine resistance in breast cancer: a comprehensive review of estrogen receptor biology, treatment options, and future directions.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.19

7 January 2021

The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2010.19

7 January 2021

Identifiers

DOI

10.1038/CGT.2010.19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20467453%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference